Tearsheet

SelectQuote (SLQT)


Market Price (12/23/2025): $1.385 | Market Cap: $257.4 Mil
Sector: Financials | Industry: Insurance Brokers

SelectQuote (SLQT)


Market Price (12/23/2025): $1.385
Market Cap: $257.4 Mil
Sector: Financials
Industry: Insurance Brokers

Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.


0 Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 24%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 20%
Weak multi-year price returns
2Y Excs Rtn is -50%
Debt is significant
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 161%
1 Valuation becoming less expensive
P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -43%
  Not cash flow generative
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -1.1%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -1.9%
2 Megatrend and thematic drivers
Megatrends include Aging Population & Chronic Disease, E-commerce & Digital Retail, and Digital Health & Telemedicine. Themes include Geriatric Care, Show more.
  Key risks
SLQT key risks include [1] a U.S. Show more.
0 Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 24%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 20%
1 Valuation becoming less expensive
P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -43%
2 Megatrend and thematic drivers
Megatrends include Aging Population & Chronic Disease, E-commerce & Digital Retail, and Digital Health & Telemedicine. Themes include Geriatric Care, Show more.
3 Weak multi-year price returns
2Y Excs Rtn is -50%
4 Debt is significant
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 161%
5 Not cash flow generative
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -1.1%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -1.9%
6 Key risks
SLQT key risks include [1] a U.S. Show more.

Valuation, Metrics & Events

SLQT Stock


Why The Stock Moved


Qualitative Assessment

AI Analysis | Feedback

1. Missed Earnings and Revenue Estimates

SelectQuote missed analyst expectations for its Q3 earnings and revenue in May 2025. Additionally, the company reported a Q1 FY2026 earnings per share (EPS) of -$0.260 in November 2025, which was worse than analyst estimates, despite revenue topping expectations.

2. Negative Analyst Forecasts and Shaky Carrier Trends

Analyst insights indicated a concerning outlook for SelectQuote, with earnings forecast to decline significantly over the next three years, specifically by 102.4% per year, and EPS projected to decrease by 114.3% per annum. This negative forecast was partly attributed to "shaky carrier trends" impacting confidence in the company.

Show more

Stock Movement Drivers

Fundamental Drivers

The -32.7% change in SLQT stock from 9/22/2025 to 12/22/2025 was primarily driven by a -47.6% change in the company's P/E Multiple.
922202512222025Change
Stock Price ($)2.051.38-32.68%
Change Contribution ByLTMLTM
Total Revenues ($ Mil)1526.591563.142.39%
Net Income Margin (%)3.12%3.95%26.58%
P/E Multiple7.944.16-47.61%
Shares Outstanding (Mil)184.21185.82-0.87%
Cumulative Contribution-32.69%

LTM = Last Twelve Months as of date shown

Market Drivers

9/22/2025 to 12/22/2025
ReturnCorrelation
SLQT-32.7% 
Market (SPY)2.7%37.4%
Sector (XLF)2.4%41.9%

Fundamental Drivers

The -38.4% change in SLQT stock from 6/23/2025 to 12/22/2025 was primarily driven by a -96.1% change in the company's P/E Multiple.
623202512222025Change
Stock Price ($)2.241.38-38.39%
Change Contribution ByLTMLTM
Total Revenues ($ Mil)1488.701563.145.00%
Net Income Margin (%)0.25%3.95%1489.45%
P/E Multiple108.004.16-96.15%
Shares Outstanding (Mil)178.16185.82-4.30%
Cumulative Contribution-38.51%

LTM = Last Twelve Months as of date shown

Market Drivers

6/23/2025 to 12/22/2025
ReturnCorrelation
SLQT-38.4% 
Market (SPY)14.4%24.5%
Sector (XLF)9.2%28.4%

Fundamental Drivers

The -54.5% change in SLQT stock from 12/22/2024 to 12/22/2025 was primarily driven by a -56.1% change in the company's P/S Multiple.
1222202412222025Change
Stock Price ($)3.031.38-54.46%
Change Contribution ByLTMLTM
Total Revenues ($ Mil)1381.311563.1413.16%
P/S Multiple0.370.16-56.12%
Shares Outstanding (Mil)170.43185.82-9.03%
Cumulative Contribution-54.83%

LTM = Last Twelve Months as of date shown

Market Drivers

12/22/2024 to 12/22/2025
ReturnCorrelation
SLQT-54.5% 
Market (SPY)16.9%27.8%
Sector (XLF)15.7%30.8%

Fundamental Drivers

The 112.5% change in SLQT stock from 12/23/2022 to 12/22/2025 was primarily driven by a 102.9% change in the company's Total Revenues ($ Mil).
1223202212222025Change
Stock Price ($)0.651.38112.47%
Change Contribution ByLTMLTM
Total Revenues ($ Mil)770.451563.14102.89%
P/S Multiple0.140.1618.06%
Shares Outstanding (Mil)164.82185.82-12.74%
Cumulative Contribution109.02%

LTM = Last Twelve Months as of date shown

Market Drivers

12/23/2023 to 12/22/2025
ReturnCorrelation
SLQT-9.2% 
Market (SPY)47.7%28.6%
Sector (XLF)52.0%30.4%

Return vs. Risk


Price Returns Compared

 202020212022202320242025Total [1]
Returns
SLQT Return�-56%-93%104%172%-64%�
Peers Return��-63%15%78%8%�
S&P 500 Return16%27%-19%24%23%17%113%

Monthly Win Rates [3]
SLQT Win Rate43%50%17%50%50%42% 
Peers Win Rate�30%30%55%60%50% 
S&P 500 Win Rate58%75%42%67%75%73% 

Max Drawdowns [4]
SLQT Max Drawdown�-62%-94%-7%-25%-64% 
Peers Max Drawdown��-80%-33%-28%-43% 
S&P 500 Max Drawdown-31%-1%-25%-1%-2%-15% 


[1] Cumulative total returns since the beginning of 2020
[2] Peers: EHTH, GOCO, EVER, LMND, HIPO.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 12/22/2025 (YTD)

How Low Can It Go

Unique KeyEventSLQTS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-98.4%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven6007.9%34.1%
2022 Inflation ShockTime to BreakevenTime to BreakevenNot Fully Recovered days464 days
2020 Covid Pandemic2020 Covid Pandemic  
2020 Covid Pandemic% Loss% Loss-41.3%-33.9%
2020 Covid Pandemic% Gain to Breakeven% Gain to Breakeven70.3%51.3%
2020 Covid PandemicTime to BreakevenTime to Breakeven109 days148 days

Compare to NP, WTW, MMC, AON, AJG

In The Past

SelectQuote's stock fell -98.4% during the 2022 Inflation Shock from a high on 4/6/2021. A -98.4% loss requires a 6007.9% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About SelectQuote (SLQT)

SelectQuote, Inc. operates a technology-enabled, direct-to-consumer distribution platform that sells a range of insurance policies to consumers from various insurance carriers in the United States. The company operates through three segments: Senior; Life; and Auto & Home. It distributes senior health policies, such as medicare advantage, medicare supplement, medicare part D, and other ancillary senior health insurance related policies, including prescription drugs, dental, vision, and hearing plans; term life policies; and non-commercial auto and home property, and casualty policies. The company was incorporated in 1999 and is headquartered in Overland Park, Kansas.

AI Analysis | Feedback

LendingTree for insurance

Kayak for insurance

AI Analysis | Feedback

  • Senior Insurance: Connects seniors with Medicare Advantage, Medicare Supplement, and Prescription Drug Plans from various carriers.
  • Life Insurance: Offers term life and whole life insurance policies to individuals and families from a diverse panel of insurance providers.
  • Auto & Home Insurance: Provides quotes and policies for automobile and homeowners' insurance through multiple carriers.

AI Analysis | Feedback

```html

SelectQuote (SLQT) primarily sells to **individuals**, acting as a direct-to-consumer insurance broker. It connects individual consumers with various insurance carriers.

The company serves the following categories of individual customers:

  1. Seniors: This category includes individuals eligible for Medicare who are seeking Medicare Advantage, Medicare Supplement, or Prescription Drug Plans.

  2. Life Insurance Seekers: This category comprises individuals looking for term life or whole life insurance policies to protect their families and assets.

  3. Auto & Home Insurance Seekers: This category consists of individuals looking for property and casualty insurance products, such as auto insurance and homeowners or renters insurance.

```

AI Analysis | Feedback

  • UnitedHealth Group (UNH)
  • Humana Inc. (HUM)
  • CVS Health Corporation (CVS)
  • Elevance Health Inc. (ELV)
  • Centene Corporation (CNC)

AI Analysis | Feedback

Timothy "Tim" Danker, Chief Executive Officer

Timothy "Tim" Danker has served as CEO of SelectQuote since 2017. He co-founded and served as Chief Executive Officer of Spring Venture Group, a direct-to-consumer insurance brokerage, from 2007 to 2012, before joining SelectQuote in 2010. Prior to his CEO role, he held various leadership positions within SelectQuote, including President of the Life division (2016-2019), Executive Vice President of the Life division (2015-2016), and President of the Auto & Home division (2012-2015). Danker has also held leadership roles at companies such as Cerner and Sprint.

Ryan Clement, Chief Financial Officer

Ryan Clement joined SelectQuote in January 2022 and was appointed Chief Financial Officer in February 2023, after serving as Interim CFO since May 2022. Before joining SelectQuote, he served as the Chief Financial Officer of Sifted (formerly VeriShip), a SaaS-based logistics software company. Clement also spent seven years at Edelman Financial Engines, a registered investment advisory firm, where he held various senior finance and operational roles. His career also includes roles at The Mutual Fund Store and Freightquote.com, Inc.

William "Bill" Grant III, Chief Operating Officer

William "Bill" Grant III has served as the Chief Operating Officer of SelectQuote since 2019. His previous roles at the company include Chief Marketing Officer and President of the Senior division from 2017 to 2019, and Senior Vice President of Marketing for the Senior division for five years prior to that.

Trevor Nohe, Chief Business Officer

Trevor Nohe has served as the Chief Business Officer at SelectQuote since 2022. Before joining SelectQuote in 2020, he was the CEO of Inside Response for five years and also served as CEO of Inside Academics. His background also includes experience as a management consultant for Deloitte Consulting and as a private equity investor at Five Elms Capital.

Daniel "Al" Boulware, General Counsel and Secretary

Daniel "Al" Boulware has served as SelectQuote's General Counsel and Secretary since 2019. Previously, he was the Vice President and General Counsel for SS&C Health, the healthcare segment of SS&C Technologies Holdings, Inc. He also worked as a Shareholder and an associate at Polsinelli, P.C.

AI Analysis | Feedback

The key risks to SelectQuote's business are:

Legal and Regulatory Scrutiny

SelectQuote faces significant legal and regulatory challenges, notably a lawsuit filed by the U.S. Department of Justice (DOJ). The lawsuit alleges violations of the False Claims Act, accusing the company of receiving substantial illegal kickbacks from health insurers and steering Medicare beneficiaries toward plans that offered the highest commissions, rather than those best suited to the beneficiaries' needs. This has resulted in a notable drop in SelectQuote's stock price, the initiation of a securities class-action lawsuit, and concerns regarding potential fines, reputational damage, and operational disruptions.

High Debt Load and Financial Stability

The company exhibits a substantial reliance on debt financing, indicated by a debt-to-equity ratio of 2.27. This significant debt load raises concerns about SelectQuote's financial stability and its capacity to manage its obligations, particularly given its history of unprofitability.

Industry Headwinds, Competition, and Business Model Sustainability

SelectQuote is affected by broader industry challenges, including carrier plan changes that have negatively impacted policy retention and new customer acquisition. Insurance carriers are increasingly prioritizing their margins over policy growth, which directly diminishes SelectQuote's potential commission earnings. Furthermore, intense competition from direct-to-consumer digital platforms offered by insurers and pharmacies poses a threat to SelectQuote's market relevance and long-term revenue growth. The company also grapples with high customer acquisition costs and the risk of commoditization, which challenge its margin stability and growth. Despite experiencing revenue growth, SelectQuote has struggled with consistent profitability, reporting net losses in recent years, which leads to questions about the long-term sustainability of its business model.

AI Analysis | Feedback

Intensifying competition from insurance carriers directly investing in their own robust digital direct-to-consumer sales channels.

Evolving and stricter regulatory requirements for insurance sales, particularly within the Medicare market.

AI Analysis | Feedback

SelectQuote (SLQT) operates in several large addressable markets within the U.S. for its main products and services:

  • The total addressable market for the insurance products SelectQuote distributes is estimated to be greater than $180 billion in the U.S.
  • For healthcare services provided by its Population Health segment, the total addressable market in the U.S. is in excess of $1 trillion.
  • The Senior segment, which focuses on products for Medicare beneficiaries, presents an annual commission revenue opportunity of approximately $30 billion in the U.S.
  • The Life segment addresses a market with an annual commission revenue opportunity of approximately $105 billion in the U.S.
  • The Auto & Home segments target markets with an estimated annual commission revenue opportunity of approximately $47 billion in the U.S.
  • Within Population Health, the U.S. Pharmaceutical total addressable market is over $500 billion.

AI Analysis | Feedback

SelectQuote (SLQT) is anticipated to drive future revenue growth over the next 2-3 years through several key strategies and market dynamics:

  1. Growth in Healthcare Services and SelectRx: The company expects significant growth from its Healthcare Services segment, particularly through its SelectRx program. This program has shown success in improving medication adherence and reducing hospital days, contributing to strong revenue growth and membership increases. Despite some near-term challenges with drug reimbursement rates, SelectQuote remains confident in the long-term economics and expansion of this business.
  2. Expansion in the Life Insurance Business: SelectQuote's life insurance segment, encompassing term life and final expense policies, has consistently demonstrated revenue growth. The company continues to be pleased with the performance of this business, indicating it as a contributor to overall revenue expansion.
  3. Improved Agent Productivity and Efficiency via Technology and AI: SelectQuote is focused on leveraging technological advancements and artificial intelligence to enhance agent efficiency, reduce variable costs, and accelerate customer acquisition. This includes routing a significant number of calls through automation and powering healthcare services interactions with AI, which has led to reductions in agent enrollment time and health assessment time.
  4. Strategic Market Expansions and Product Diversification: The company aims to expand into underserved geographic markets and demographic segments. Furthermore, SelectQuote is diversifying its product offerings beyond traditional insurance into areas such as pharmacy, telehealth, and patient management to meet evolving consumer needs and capture new revenue streams.
  5. Sustained Performance in the Senior Segment (Medicare Advantage): While the senior segment experienced a decline in revenue in Q1 Fiscal Year 2026 due to changes in beneficiary eligibility requirements, SelectQuote has historically delivered robust results during the Annual Enrollment Period (AEP) with strong agent productivity and high close rates. The company continues to manage this segment to drive increasing cash flow and anticipates strong performance in upcoming enrollment seasons, leveraging its Medicare Advantage engine for growth when market conditions are favorable.

AI Analysis | Feedback

Share Repurchases

  • SelectQuote did not repurchase any common stock during the fiscal year ended June 30, 2021.

Share Issuance

  • In May 2020, SelectQuote completed its initial public offering (IPO), issuing 18,000,000 shares of common stock at $20.00 per share, raising approximately $360 million.
  • In March 2021, selling stockholders conducted a secondary public offering of 10,600,000 shares at $27.50 per share, from which SelectQuote itself did not sell any shares or receive proceeds.
  • The number of shares issued and outstanding increased from approximately 163.65 million as of August 2021 to around 175.95 million as of September 2025.

Inbound Investments

  • In February/March 2025, SelectQuote closed a $350 million strategic investment from funds managed by Bain Capital, Morgan Stanley Private Credit, and Newlight Partners.
  • The proceeds from this investment were intended to recapitalize the balance sheet, lower debt service, provide liquidity, and fund growth initiatives, with $260 million used to pay down an outstanding term loan.
  • In October 2024, the company completed a $100 million Medicare Advantage commissions receivable securitization to improve capital flexibility and reduce its cost of capital.

Outbound Investments

  • Information regarding significant outbound strategic investments or acquisitions by SelectQuote in other companies was not readily available within the provided search results for the specified period.

Capital Expenditures

  • Capital expenditures were reported as $25 million for fiscal year 2022, $9.13 million for fiscal year 2023, and $11 million for fiscal year 2024.
  • The company planned to use a portion of its IPO proceeds (May 2020) for capital expenditures, working capital, and general corporate purposes.

Better Bets than SelectQuote (SLQT)

Trade Ideas

Select ideas related to SLQT. For more, see Trefis Trade Ideas.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
WU_11212025_Dip_Buyer_FCFYield11212025WUWestern UnionDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
13.5%13.5%-0.4%
COIN_11212025_Monopoly_xInd_xCD_Getting_Cheaper11212025COINCoinbase GlobalMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple
3.1%3.1%-0.5%
PYPL_11142025_Dip_Buyer_FCFYield11142025PYPLPayPalDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
-4.7%-4.7%-7.5%
V_11142025_Monopoly_xInd_xCD_Getting_Cheaper11142025VVisaMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple
6.7%6.7%-2.7%
WD_11072025_Dip_Buyer_ValueBuy11072025WDWalker & DunlopDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin
-10.3%-10.3%-12.1%

Recent Active Movers

More From Trefis

Peer Comparisons for SelectQuote

Peers to compare with:

Financials

SLQTEHTHGOCOEVERLMNDHIPOMedian
NameSelectQu.eHealth GoHealth EverQuoteLemonade Hippo  
Mkt Price1.384.442.4727.3782.5231.2515.91
Mkt Cap0.30.10.01.06.10.80.5
Rev LTM1,563543738645659450652
Op Inc LTM4055-4060--47
FCF LTM-29-33-7984-33-12-31
FCF 3Y Avg-8-24-2438-75-47-24
CFO LTM-17-17-6889-23-0-17
CFO 3Y Avg3-11-1242-65-23-12

Growth & Margins

SLQTEHTHGOCOEVERLMNDHIPOMedian
NameSelectQu.eHealth GoHealth EverQuoteLemonade Hippo  
Rev Chg LTM13.2%16.8%7.6%57.8%33.5%34.5%25.2%
Rev Chg 3Y Avg27.1%7.1%-3.4%20.7%49.5%58.5%23.9%
Rev Chg Q12.5%-7.8%-71.1%20.3%42.4%26.3%16.4%
QoQ Delta Rev Chg LTM2.4%-0.8%-10.2%4.8%9.6%5.9%3.6%
Op Mgn LTM2.5%10.1%-5.5%9.3%--5.9%
Op Mgn 3Y Avg3.5%-2.1%-19.2%1.1%---0.5%
QoQ Delta Op Mgn LTM-1.9%0.5%-5.3%0.5%---0.7%
CFO/Rev LTM-1.1%-3.1%-9.2%13.7%-3.6%-0.1%-2.1%
CFO/Rev 3Y Avg0.3%-2.1%-1.6%7.6%-14.9%-13.1%-1.8%
FCF/Rev LTM-1.9%-6.1%-10.7%13.0%-5.0%-2.6%-3.8%
FCF/Rev 3Y Avg-0.5%-4.9%-3.5%6.6%-16.7%-23.9%-4.2%

Valuation

SLQTEHTHGOCOEVERLMNDHIPOMedian
NameSelectQu.eHealth GoHealth EverQuoteLemonade Hippo  
Mkt Cap0.30.10.01.06.10.80.5
P/S0.20.30.01.59.31.70.9
P/EBIT2.22.4-0.116.5--2.3
P/E4.22.7-0.218.4-35.28.23.4
P/CFO-15.4-8.0-0.511.2-261.6-1,967.5-11.7
Total Yield24.0%37.0%-570.0%5.4%-2.8%12.2%8.8%
Dividend Yield0.0%0.0%0.0%0.0%0.0%0.0%0.0%
FCF Yield 3Y Avg-2.6%-18.8%-35.3%3.7%-7.5%-22.3%-13.2%
D/E1.60.717.70.00.00.10.4
Net D/E1.60.116.7-0.1-0.1-0.60.0

Returns

SLQTEHTHGOCOEVERLMNDHIPOMedian
NameSelectQu.eHealth GoHealth EverQuoteLemonade Hippo  
1M Rtn-2.8%28.0%-3.9%11.8%22.5%-3.2%4.5%
3M Rtn-32.7%11.8%-46.7%10.1%38.3%-14.5%-2.2%
6M Rtn-38.4%11.3%-54.2%14.8%80.2%9.4%10.3%
12M Rtn-54.5%-46.6%-80.7%56.3%98.7%18.9%-13.9%
3Y Rtn112.5%0.2%-81.0%77.0%473.1%158.5%94.8%
1M Excs Rtn-2.2%28.7%2.2%11.9%16.2%-6.2%7.0%
3M Excs Rtn-37.0%4.4%-49.4%12.8%40.1%-15.5%-5.5%
6M Excs Rtn-53.9%-10.6%-70.3%0.7%70.8%-0.9%-5.8%
12M Excs Rtn-72.9%-62.3%-97.1%45.8%93.5%7.4%-27.4%
3Y Excs Rtn20.6%-83.9%-159.5%77.9%335.0%49.7%35.2%

Financials

Segment Financials

Revenue by Segment
$ Mil20252024202320222021
Senior656590528729362
Healthcare Services47925270  
Life158146154178130
All other3622283141
Eliminations of intersegment revenues-7-7-16-7-1
Total1,3221,003764930532


Price Behavior

Price Behavior
Market Price$1.38 
Market Cap ($ Bil)0.3 
First Trading Date05/21/2020 
Distance from 52W High-77.2% 
   50 Days200 Days
DMA Price$1.66$2.28
DMA Trenddowndown
Distance from DMA-16.7%-39.4%
 3M1YR
Volatility67.7%85.3%
Downside Capture397.71234.83
Upside Capture157.57122.22
Correlation (SPY)36.4%27.7%
SLQT Betas & Captures as of 11/30/2025

 1M2M3M6M1Y3Y
Beta1.942.012.061.991.212.10
Up Beta-2.45-0.930.132.600.481.77
Down Beta0.261.511.862.441.562.06
Up Capture37%165%103%78%135%3231%
Bmk +ve Days13263974142427
Stock +ve Days9202548102348
Down Capture451%343%333%226%146%111%
Bmk -ve Days7162452107323
Stock -ve Days11203371137368

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
 Comparison of SLQT With Other Asset Classes (Last 1Y)
 SLQTSector ETFEquityGoldCommoditiesReal EstateBitcoin
Annualized Return-58.8%14.3%14.7%67.3%6.8%-0.5%-16.6%
Annualized Volatility85.1%19.3%19.7%19.3%15.2%17.6%35.4%
Sharpe Ratio-0.690.570.572.540.23-0.18-0.25
Correlation With Other Assets 31.5%28.7%0.3%7.3%23.3%14.5%

ETFs used for asset classes: Sector ETF = XLF, Equity = SPY, Gold = GLD, Commodities = DBC, Real Estate = VNQ, and Bitcoin = BTCUSD
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
 Comparison of SLQT With Other Asset Classes (Last 5Y)
 SLQTSector ETFEquityGoldCommoditiesReal EstateBitcoin
Annualized Return-43.0%16.5%15.0%18.9%11.8%5.1%35.8%
Annualized Volatility104.3%18.9%17.1%15.5%18.7%18.9%48.9%
Sharpe Ratio-0.050.730.710.980.510.180.63
Correlation With Other Assets 32.5%35.0%0.6%8.7%30.4%16.4%

ETFs used for asset classes: Sector ETF = XLF, Equity = SPY, Gold = GLD, Commodities = DBC, Real Estate = VNQ, and Bitcoin = BTCUSD
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
 Comparison of SLQT With Other Asset Classes (Last 10Y)
 SLQTSector ETFEquityGoldCommoditiesReal EstateBitcoin
Annualized Return-41.4%13.4%14.9%14.9%6.7%5.5%69.9%
Annualized Volatility100.3%22.3%18.0%14.8%17.6%20.8%55.8%
Sharpe Ratio-0.060.550.710.840.300.230.90
Correlation With Other Assets 29.4%33.7%1.0%8.5%28.8%16.2%

ETFs used for asset classes: Sector ETF = XLF, Equity = SPY, Gold = GLD, Commodities = DBC, Real Estate = VNQ, and Bitcoin = BTCUSD
Smart multi-asset allocation framework can stack odds in your favor. Learn How

Short Interest

Short Interest: As Of Date11282025
Short Interest: Shares Quantity2,927,680
Short Interest: % Change Since 11152025-5.5%
Average Daily Volume804,250
Days-to-Cover Short Interest3.64
Basic Shares Quantity185,816,000
Short % of Basic Shares1.6%

Earnings Returns History

Expand for More
 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
11/6/2025-21.1%-23.9%-36.6%
8/21/202541.5%31.7%12.0%
5/12/2025-12.0%-14.2%-17.6%
2/10/202530.8%38.1%-17.4%
9/13/2024-43.7%-44.3%-37.6%
5/9/20243.6%17.6%13.2%
2/7/20240.9%34.2%58.6%
9/13/2023-16.2%-10.3%-12.5%
...
SUMMARY STATS   
# Positive887
# Negative101011
Median Positive10.8%24.6%13.2%
Median Negative-20.6%-23.3%-24.9%
Max Positive41.5%38.1%58.6%
Max Negative-47.3%-56.8%-59.6%

SEC Filings

Expand for More
Report DateFiling DateFiling
93020251106202510-Q 9/30/2025
6302025821202510-K 6/30/2025
3312025512202510-Q 3/31/2025
12312024210202510-Q 12/31/2024
93020241104202410-Q 9/30/2024
6302024913202410-K 6/30/2024
3312024509202410-Q 3/31/2024
12312023208202410-Q 12/31/2023
93020231103202310-Q 9/30/2023
6302023913202310-K 6/30/2023
3312023510202310-Q 3/31/2023
12312022207202310-Q 12/31/2022
93020221103202210-Q 9/30/2022
6302022829202210-K 6/30/2022
3312022505202210-Q 3/31/2022
12312021214202210-Q 12/31/2021